Communities›Triple-negative Breast Cancer›What new TNBC treatments like DATROWAY should I know about?

What new TNBC treatments like DATROWAY should I know about?

Community Member

6 days ago

I had triple negative breast cancer and finished my initial treatment in 2022 with great results (complete response). I just read about DATROWAY (datopotamab deruxtecan), a new treatment that's being reviewed by the FDA for metastatic triple negative breast cancer patients who can't receive immunotherapy. While this doesn't apply to my current situation since my cancer hasn't spread, I'm interested in staying informed about new options that might be available in the future. For those of you who have dealt with metastatic TNBC or are currently facing treatment decisions: • Have you heard about or considered newer targeted treatments like antibody-drug conjugates? • What has your experience been with staying informed about emerging treatment options? Link: https://daiichisankyo.us/press-releases/-/article/datroway-granted-priority-review-in-the-us-as-first-line-treatment-for-patients-with-metastatic-triple-negative-breast-cancer-who-are-not-candidates-for-immunotherapy

1 comment

Comment

Community Member

6 days ago

It's wonderful that you achieved a complete response and are staying proactive about learning new treatment options. Antibody-drug conjugates like datopotamab deruxtecan represent an exciting area of research for TNBC, offering more targeted approaches that could provide additional options for patients who may need them in the future. Staying informed about emerging therapies can help patients feel more prepared and empowered in their cancer journey, and connecting with others in the community who have experience with newer treatments can provide valuable insights about navigating these evolving options.

New to the community?

Create an account to connect with others navigating cancer.

What new TNBC treatments like DATROWAY should I know about?

Related Questions